---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-24-109285"
form_type: "8-K"
ticker: "ESLA"
cik: "0001844417"
company_name: "Estrella Immunopharma, Inc."
filed_at: "2024-12-16T23:59:59+00:00"
generated_at: "2026-05-29T03:05:56.657815+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# Estrella Immunopharma regains compliance with both Nasdaq listing requirements

## Summary
- Regained compliance with Stockholders' Equity Requirement after market value of listed securities exceeded $35M for 10 consecutive days ending Dec 10, 2024.
- Regained compliance with Minimum Bid Price Requirement after closing bid price of common stock stayed at $1.00+ for 10 consecutive days ending Dec 10, 2024.
- Both Nasdaq deficiency matters are now closed; no further action required.

## SEC filing metadata
- accession: 0001213900-24-109285
- form_type: 8-K
- ticker: ESLA
- cik: 0001844417
- company_name: Estrella Immunopharma, Inc.
- filed_at: 2024-12-16T23:59:59+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1844417/000121390024109285/0001213900-24-109285-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1844417/000121390024109285/ea0224902-8k_estella.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-24-109285
- JSON: https://secwatch.observer/filing/0001213900-24-109285.json
- Plain text: https://secwatch.observer/filing/0001213900-24-109285.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.